Stock listing
NASDAQ:INZY Inozyme Pharma Inc Stock
Follow Inozyme Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:INZY
$4.00 USD
Close on Jul 2, 2025 · No longer trades
- Lowest – highest close
- $0.821 – $30.20 USDSince Jul 24, 2020 · lowest Apr 4, 2025 · highest Sep 1, 2020
Delisted NASDAQ:INZY no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:INZY
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Inozyme Pharma Inc on 6ix
- Decks
- 2 decks · latest Jan 10, 2025
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (January 2025) | Technical | 25 slides | Jan 10, 2025 |
| Technical Presentation (May 2024) | Technical | 19 slides | May 26, 2024 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Edward Mathers Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Senti Biosciences Holdings, Inc. (Director · Since at least Jun 8, 2022); OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Ra Pharmaceuticals Inc (Director · Jun 28, 2018 – Apr 2, 2020 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past) | Director · Jul 23, 2020 – Jun 18, 2024 · Past |
| Stephen J DiPalma Other companies: Solid Biosciences Inc. (Interim CFO · Jan 29, 2021 – Jan 29, 2021 · Past); Generation Bio Co (See Remarks · Jun 11, 2020 – Jun 11, 2020 · Past); Chemomab Therapeutics Ltd. (Chief Financial Officer · May 1, 2020 – May 1, 2020 · Past); Spero Therapeutics, Inc. (See Remarks · Nov 8, 2019 – Jul 15, 2023 · Past); Interleukin Genetics Inc (Interim CFO · Jul 29, 2016 – Jul 29, 2016 · Past) | Interim CFO · May 17, 2021 – May 17, 2021 · Past |
| Lynne Sullivan Other companies: Solid Biosciences Inc. (Chief Financial Officer at Unity Biotechnology · Since at least Jan 25, 2018); Unity Biotechnology Inc (CFO & Head of Corp. Dev. · Aug 1, 2020 – Apr 2, 2025 · Past); BiomX Inc. (Director · Nov 4, 2019 – Mar 1, 2023 · Past); Adicet Bio, Inc. (Director · Jan 25, 2018 – Jun 3, 2020 · Past) | Director · Since at least Jul 23, 2020 |
| Erik Harris Other companies: Rezolute, Inc. (Board Member · Since at least Mar 25, 2025); Ultragenyx Pharmaceutical Inc. (EVP & Chief Commercial Officer · Since at least Jun 11, 2019); Denali Therapeutics Inc. (Director · Feb 3, 2022 – May 31, 2024 · Past) | Director · Oct 3, 2024 – Oct 3, 2024 · Past |
| Sanjay Subramanian Other companies: Scynexis, Inc. (Chief Financial Officer · Since at least Sep 9, 2026); Ocugen, Inc. (Chief Financial Officer · Oct 1, 2019 – Jan 3, 2022 · Past) | SVP, CFO & Head of BD · Since at least Mar 21, 2022 |
| Matthew Winton Other companies: CervoMed Inc. (Chief Commercial and Business Officer · Since at least Oct 6, 2025) | COO · Since at least Mar 13, 2024 |
| Stephen Basso Other companies: Innoviva, Inc. (Chief Financial Officer · Since at least Aug 21, 2023) | SVP Finance (PFO) · Jul 23, 2020 – Mar 24, 2021 · Past |
Log in to ask 6ix AI your own questions about Inozyme Pharma Inc.